Teva Pharmaceutical Industries (TEVA) Shares Outstanding (2009 - 2026)

Teva Pharmaceutical Industries' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 1.44% year-over-year to $1.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (up 1.44% YoY) and the FY2025 annual result came in at $1.3 billion, up 8.33% from the prior year.
• Shares Outstanding (Entity) was $1.3 billion for Q1 2026 at Teva Pharmaceutical Industries, down from $1.3 billion in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $1.3 billion in Q4 2025 and bottomed at $1.1 billion in Q2 2022.
• A 5-year average of $1.2 billion and a median of $1.2 billion in 2023 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) retreated 8.19% — and 2023, when it advanced 10.54%.
• Teva Pharmaceutical Industries' Shares Outstanding (Entity) stood at $1.2 billion in 2022, then changed by 0.0% to $1.2 billion in 2023, then changed by 0.0% to $1.2 billion in 2024, then increased by 8.33% to $1.3 billion in 2025, then fell by 2.23% to $1.3 billion in 2026.
• Business Quant data shows TEVA's Shares Outstanding (Entity) at $1.3 billion in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.